News
Media
Conferences
Publication
Job Board
CME/CE
Partners
Editorial
Resources
Subscribe

Spotlight -

Long-Acting Injectable Therapy in the Management of Adult Patients with Schizophrenia|

Major Depressive Disorder

John W. Tsuang, MD

Articles by John W. Tsuang, MD

An Update on Street and Club Drugs: What Clinicians Need to Know

ByLynn Yen, MD,John W. Tsuang, MD

April 30th 2015

A review of the pharmacological and symptomatic effects of various classes of designer drugs, including stimulants, hallucinogens, and sedatives.

Latest Updated Articles

An Update on Street and Club Drugs: What Clinicians Need to Know
Published: April 30th 2015 | Updated:

Trending on Psychiatric Times

Mentalization-Based Treatment: A Promising Approach for Pathological Narcissism

FDA Approves Caplyta for Adjunctive Treatment of Major Depressive Disorder

Thanks

Week In Review: November 3-7

Working With Pediatric ADHD, Advice from Stacy Doumas, MD, MBA

© 2025 MJH Life Sciences^®

All rights reserved.